Let’s be real: even with the best intentions, AI systems can reflect our own unconscious biases. As Daniel Kahneman and Amos Tversky famously demonstrated in their groundbreaking work on Prospect Theory, humans are prone to cognitive biases that influence our…
HOME > ACADEMIA
ACADEMIA
- Insurance Coverage of Fertility Treatments Could Reduce Patients’ Payments by 20-30%: Obstetrician
April 11, 2022
- Ex-JAMS President Fumimaro Takaku Dies at 91
March 28, 2022
- Exon 44-Targeted DMD Drug Hits Goals in PI/II: NCNP/Nippon Shinyaku
March 18, 2022
- Japan Researchers Test Efficacy of COVID Drugs for BA.2 Omicron Subvariant
March 11, 2022
- Infectious Diseases Society Issues Updated COVID-19 Guide
February 21, 2022
- COVID-19 Vaccines for Ages 5 to 11 Meaningful: Japan Pediatric Society
January 20, 2022
- Oita University Completes Dosing of Replicon RNA Vaccine in PI, Eyes Global PII/III
January 19, 2022
- Kyoto Univ., Takeda Succeed in Treating Muscular Dystrophy in Model Mice Using Genome Editing
December 10, 2021
- With First Ophthalmologic Biosimilar Set to Debut, Specialist Says Close Attention Required for Unexpected Side Effects
December 9, 2021
- Swift Actions to Improve Diagnostic System, Control Costs Required to Prep for Potential Aducanumab Debut: JSDR Confab
November 30, 2021
- Anti-CGRP Antibodies Cut Headaches in 70% of Patients, but Cost Will Be Major Obstacle: Specialist
October 21, 2021
- Japan Headache Society Clarifies Patients Suitable for CGRP Migraine Meds, No Drug Selection Criteria Given for Now
October 21, 2021
- For Hypertension, Entresto Expected as or More Effective than ARBs/ACE Inhibitors: Professor
October 21, 2021
- NCC Kicks Off Asia’s Clinical Data Sharing Project, Starting with Bowel Cancer
October 4, 2021
- NCC to Launch Search Portal for Cancer Genomic Data on Oct. 4; Support Drug Makers’ R&D
October 1, 2021
- Forxiga Could Treat 3 Million CKD Patients in Japan, Potentially Be 1st Choice Drug: Professor
October 1, 2021
- Evrysdi Offers New Option for SMA Patients with Scoliosis: KOL
September 29, 2021
- Use Oral Dexamethasone for COVID-19 Patients Requiring Oxygen: Scientific Societies
September 10, 2021
- Oita University to Begin PI Study for Replicon RNA Vaccine in October
September 10, 2021
- Systemic Symptoms Unlikely to Occur from Contaminated Moderna Jabs: Japan Vaccinology Society
September 9, 2021
ページ
As Japan approaches the Fiscal System Council’s “autumn recommendation,” a notable shift is taking shape. The Ministry of Finance (MOF),…
Japan is considering a new approach to its “special” market expansion re-pricing that would exclude drug sales tied to private…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…